The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cisplatin with or without rucaparib after preoperative chemotherapy in patients with triple negative breast cancer: Final efficacy results of Hoosier Oncology Group BRE09-146.
 
Kathy Miller
Consulting or Advisory Role - Clovis Oncology; ImClone Systems; Nektar
Research Funding - AVEO (Inst); BiPar Sciences (Inst); EntreMed (Inst); Genentech (Inst); Geron (Inst); ImClone Systems (Inst); Lilly (Inst); Macrogenics (Inst); Medivation (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Yan Tong
No Relationships to Disclose
 
David R Jones
No Relationships to Disclose
 
Tom Walsh
No Relationships to Disclose
 
Michael A. Danso
Honoraria - Amgen
 
Cynthia X. Ma
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Novartis
 
Paula Silverman
No Relationships to Disclose
 
Mary-Claire King
No Relationships to Disclose
 
Sunil S. Badve
No Relationships to Disclose
 
Susan M. Perkins
No Relationships to Disclose